To confirm the findings of BIRC5 expression in ovarian cancer, we performed immunofluorescent staining on tumor sections of high grade serous ovarian carcinoma (Figure 1D) and found strong immunoreactivity for survivin in tumor cell nuclei but absent in the adjacent normal tissues (Figure 1E). Here, BIRC5 is linked to neoplasm.